Capnography is the process of extensive measurement and display of concentrations or partial pressures of carbon dioxide (CO2) in the respiratory gases by using a capnograph. It accurately measure the levels of carbon dioxide released into the bloodstream. The readings are presented as a graph of expiratory CO2plotted against time or expired volume called as capnogram. A capnogram is direct monitoring of inhaled and exhaled concentrations of CO2 and an indirect monitoring of CO2 in arterial blood. There is a very small difference in pressure between arterial blood and exhaled CO2 among healthy individuals. On the other hand, a large difference between arterial blood and exhaled gas, sometimes exceeding 1kPa, is observed in people suffering from various forms of lung diseases and some forms of congenital heart diseases.
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/433
Capnography majorly depicts all the three components of respiration: metabolism, transport, and ventilation and therefore gives an excellent picture of the respiratory process. This is a major help for people who suffer from asthma and chronic obstructive pulmonary disease (COPD) as it will help in proper patient monitoring and take further medications accordingly. The American Society of Anesthesiologists (ASA) endorses end-tidal capnography as a standard of care for general anesthesia, deep sedation and moderate sedation. Other specialties include critical care and emergency medicine.
The conventional capnography devices have limitations in terms of power, size, weight and ease to use. This is addressed by the emergence of smaller capnography devices that facilitate portability and device performance. Also, among the latest devices launched is a microstream capnography, which has several advantages over the conventional capnography devices. For instance, these can be used on neonatal population and on individuals after a surgery.
Hospitals,Clinics,Ambulatory Surgical Centers,.
Recent advancements in technology of medical monitoring has enhanced the development of the capnography devices market. Recurring revenue generated from disposables will be a key driver for capnography devices market growth, as users have to buy disposables frequently to use them along with capnographs to analyze CO2. A disposable only lasts for one or two days on an average. On the other hand, reusable consumables carry contamination risks also. The Centers for Disease Control and Prevention (CDC) stated that approximately 1.7 million individuals in the U.S. get infected on the use of reusable consumables every year, of which about 99,000 individuals die. This resulted the rise in preference for disposable consumables over reusable consumables.
Rising demand for effective monitoring of carbon dioxide levels was limited due to involvement of pulse oximetry, which takes 4-5 minutes to reflect respiratory status of the individual while capnographs provides the ventilation status of individuals in real time, thereby improving patient care. According to the American Thoracic Society, approximately 360,000 respiratory failure cases every year are observed in the U.S., and of this 36% of deaths occur during hospitalization, 30% of individuals die post-surgery and up to 7% of all Medicare individuals among them in 2014 were indicated with respiratory compromise–a state characterized by respiratory failures, insufficiency, respiratory arrest or death.
Market in emerging economies is expected to augment on account of recommendations by global and government healthcare organizations
North America dominates the global capnography devices market due to rampant development of advanced products in the region. Latin America capnography devices industry is experiencing a significant growth majorly due to the recommendations to use capnography in routine hospital settings by esteemed organizations and government bodies. The World Health Organization (WHO) published a report on safe surgery in 2009 that recommended the use of capnography monitoring devices during endotracheal tube placement, hypoventilation and esophageal intubation for better possible outcomes in patients. The Uruguayan Society of Anesthesiologists and the American Society of Anesthesiologists also recommends the usage of capnography monitoring in routine-use during procedural sedation and anesthetics. These guidelines by the organizations substantiate the importance of capnography equipment in hospital use.
Product innovation by market players contributing towards capnography devices market growth
Key players in capnography devices market include Dragerwerk AG & Co. KGaA., Welch Allyn, Inc., Smiths Medical, Medtronic, Inc., Philips Healthcare, Masimo, Nonin Medical, Inc., Nihon Kohden Corporation, CareFusion Corporation and Dia Medica, Inc. Medtronic recently introduced a global study on opioid induced respiratory depression (OIRD), a preventable form of respiratory condition in 2017. It also claims that it is the first study to use capnography in patients undergoing opioid medication. Also Masimo announces the release of Early Warning Score (EWS) on the root patient monitoring and connectivity hub by launch of NomoLine. These strategies aims to help physicians to understand the true incidence of respiratory compromise and relate issues that has been ignored otherwise.
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/433
Capnography Devices Market taxonomy:
On the basis of technology, the global market is classified into:
Capnographs,Mainstream capnographs,Sidestream capnographs,Microstream capnographs,Disposables,.
On the basis of device type, the global market is classified into: